Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Cardiovascular Outcomes in Transthyretin Amyloid Cardiomyopathy
Stefano Byer, Aravinthasamy Sivamurugan, Udhayvir Singh Grewal, Michael G Fradley, Paari Dominic
Topics & Concepts
TransthyretinMedicineCardiomyopathyInternal medicineAmyloid (mycology)Amyloid fibrilCotransporterCardiologyEndocrinologyAmyloid βSodiumChemistryPathologyHeart failureDiseaseOrganic chemistryAmyloidosis: Diagnosis, Treatment, OutcomesParathyroid Disorders and TreatmentsDiabetes Treatment and Management